MediWound Ltd

MDWD51

$18.11arrow_drop_up1.14%$0.20

MDWD51

$18.11

arrow_drop_up1.14%$0.20

Performance History

Key Stats
Open	$17.85
Prev. Close	$17.97
EPS	-2.16
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$184.23M
PE Ratio	-

	LOW	HIGH
Day Range	17.38	18.27
52 Week Range	7.45	24.00

Ratios







EPS	-2.16

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About MediWound Ltd (MDWD)

MediWound Ltd (MDWD) is a biotechnology company that focuses on developing innovative therapies for severe burns and chronic wounds. The company was founded in 2001 and is headquartered in Yavne, Israel. MDWD has a strong portfolio of products that are designed to address the unmet needs of patients suffering from these debilitating conditions.

One of MDWD's key products is NexoBrid, a topical enzymatic debridement agent that is used to remove dead or damaged tissue from severe burns. NexoBrid has been shown to be more effective than traditional surgical debridement methods, as it can selectively remove only the necrotic tissue while preserving the healthy tissue. This reduces the need for multiple surgeries and can significantly improve patient outcomes.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO
Headquarters: Yavne
Employees: 83
Exchange: NASDAQ

Keep an eye on MediWound Ltd

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is MediWound Ltd's (MDWD) price per share?

The current price per share for MediWound Ltd (MDWD) is $18.11. The stock has seen a price change of $0.21 recently, indicating a 1.14% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for MediWound Ltd (MDWD)?

For MediWound Ltd (MDWD), the 52-week high is $24, which is 32.52% from the current price. The 52-week low is $7.45, the current price is 143.09% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is MediWound Ltd (MDWD) a growth stock?

MediWound Ltd (MDWD) has shown an average price growth of -1.93% over the past three years. It has received a score of 72 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying MediWound Ltd as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is MediWound Ltd (MDWD) stock price performance year to date (YTD)?

As of the latest data, MediWound Ltd (MDWD) has a year-to-date price change of 60.98%. Over the past month, the stock has experienced a price change of -2.27%. Over the last three months, the change has been -10.92%. Over the past six months, the figure is 3.84%. Looking at a longer horizon, the five-year price change stands at -4.88%.

help

Is MediWound Ltd (MDWD) a profitable company?

MediWound Ltd (MDWD) has a net income of -$6.72M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 15.77% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -88.56% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $18.69M, although specific revenue growth data is currently not available. The gross profit is $2.95M. Operating income is noted at -$15.5M. Furthermore, the EBITDA is -$14.5M.

help

What is the market capitalization of MediWound Ltd (MDWD)?

MediWound Ltd (MDWD) has a market capitalization of $184.23M. The average daily trading volume is 18.04, indicating the stock's liquidity and investor engagement.